Free Trial

InMode (INMD) Competitors

InMode logo
$16.79 +0.22 (+1.33%)
As of 01/17/2025 04:00 PM Eastern

INMD vs. INSP, NARI, PRCT, NVST, IRTC, NVCR, LIVN, ENOV, WRBY, and TNDM

Should you be buying InMode stock or one of its competitors? The main competitors of InMode include Inspire Medical Systems (INSP), Inari Medical (NARI), PROCEPT BioRobotics (PRCT), Envista (NVST), iRhythm Technologies (IRTC), NovoCure (NVCR), LivaNova (LIVN), Enovis (ENOV), Warby Parker (WRBY), and Tandem Diabetes Care (TNDM). These companies are all part of the "medical equipment" industry.

InMode vs.

Inspire Medical Systems (NYSE:INSP) and InMode (NASDAQ:INMD) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, media sentiment, community ranking, valuation, earnings, analyst recommendations, institutional ownership and profitability.

Inspire Medical Systems received 26 more outperform votes than InMode when rated by MarketBeat users. However, 73.85% of users gave InMode an outperform vote while only 61.31% of users gave Inspire Medical Systems an outperform vote.

CompanyUnderperformOutperform
Inspire Medical SystemsOutperform Votes
187
61.31%
Underperform Votes
118
38.69%
InModeOutperform Votes
161
73.85%
Underperform Votes
57
26.15%

Inspire Medical Systems currently has a consensus target price of $232.55, suggesting a potential upside of 30.67%. InMode has a consensus target price of $22.40, suggesting a potential upside of 33.41%. Given InMode's higher possible upside, analysts plainly believe InMode is more favorable than Inspire Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspire Medical Systems
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.73
InMode
0 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

InMode has lower revenue, but higher earnings than Inspire Medical Systems. InMode is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspire Medical Systems$624.80M8.54-$21.15M$1.07166.33
InMode$492.05M2.87$197.92M$1.859.08

InMode has a net margin of 36.26% compared to Inspire Medical Systems' net margin of 4.37%. InMode's return on equity of 21.46% beat Inspire Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Inspire Medical Systems4.37% 5.30% 4.58%
InMode 36.26%21.46%19.19%

Inspire Medical Systems has a beta of 1.32, meaning that its share price is 32% more volatile than the S&P 500. Comparatively, InMode has a beta of 2.12, meaning that its share price is 112% more volatile than the S&P 500.

94.9% of Inspire Medical Systems shares are owned by institutional investors. Comparatively, 68.0% of InMode shares are owned by institutional investors. 4.1% of Inspire Medical Systems shares are owned by company insiders. Comparatively, 6.9% of InMode shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Inspire Medical Systems had 8 more articles in the media than InMode. MarketBeat recorded 11 mentions for Inspire Medical Systems and 3 mentions for InMode. Inspire Medical Systems' average media sentiment score of 0.78 beat InMode's score of 0.21 indicating that Inspire Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspire Medical Systems
7 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
InMode
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Inspire Medical Systems and InMode tied by winning 9 of the 18 factors compared between the two stocks.

Get InMode News Delivered to You Automatically

Sign up to receive the latest news and ratings for INMD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INMD vs. The Competition

MetricInModeElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$1.41B$3.52B$5.21B$9.14B
Dividend YieldN/A1.73%5.13%4.02%
P/E Ratio9.0818.0889.3417.36
Price / Sales2.8769.461,240.0477.11
Price / Cash7.1941.1043.7535.97
Price / BookN/A3.915.314.79
Net Income$197.92M$94.49M$122.54M$225.00M
7 Day Performance5.13%4.58%0.59%2.62%
1 Month Performance-1.70%4.10%2.55%3.81%
1 Year Performance-25.68%4.21%25.29%20.10%

InMode Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INMD
InMode
3.0197 of 5 stars
$16.79
+1.3%
$22.40
+33.4%
-25.7%$1.41B$492.05M9.08480
INSP
Inspire Medical Systems
4.8651 of 5 stars
$177.97
+2.4%
$232.55
+30.7%
-11.4%$5.33B$624.80M166.331,011
NARI
Inari Medical
1.6924 of 5 stars
$79.55
+0.2%
$68.00
-14.5%
+38.4%$4.66B$493.63M-58.931,300
PRCT
PROCEPT BioRobotics
2.9036 of 5 stars
$76.02
-3.6%
$97.86
+28.7%
+66.9%$3.97B$136.19M-38.98430Positive News
Gap Down
High Trading Volume
NVST
Envista
3.4717 of 5 stars
$19.83
+3.3%
$20.21
+1.9%
-16.3%$3.41B$2.57B-2.5512,800
IRTC
iRhythm Technologies
1.3312 of 5 stars
$108.33
+1.3%
$108.45
+0.1%
-1.1%$3.39B$492.68M-22.292,000
NVCR
NovoCure
3.3166 of 5 stars
$26.17
+0.6%
$32.67
+24.8%
+87.2%$2.83B$509.34M-18.691,453Analyst Revision
LIVN
LivaNova
3.3774 of 5 stars
$48.30
+0.7%
$69.17
+43.2%
-3.9%$2.62B$1.15B115.002,900
ENOV
Enovis
3.302 of 5 stars
$46.68
+2.7%
$67.00
+43.5%
-22.0%$2.61B$1.71B-21.326,550Short Interest ↑
News Coverage
WRBY
Warby Parker
2.3634 of 5 stars
$24.57
-6.3%
$20.92
-14.9%
+86.4%$2.50B$669.77M-90.983,491Analyst Forecast
TNDM
Tandem Diabetes Care
4.5216 of 5 stars
$35.15
-6.3%
$53.81
+53.1%
+42.0%$2.31B$747.72M-18.212,400Positive News

Related Companies and Tools


This page (NASDAQ:INMD) was last updated on 1/20/2025 by MarketBeat.com Staff
From Our Partners